Clinical trials referral resource. Clinical trials with pyrazoloacridine
- PMID: 9251119
Item in Clipboard
Clinical trials referral resource. Clinical trials with pyrazoloacridine
Oncology (Williston Park).
1997 Jul.
No abstract available
Similar articles
-
Current status of pyrazoloacridine as an anticancer agent.Invest New Drugs. 1999;17(1):43-8. doi: 10.1023/a:1006242321596. Invest New Drugs. 1999. PMID: 10555121 Review.
-
Status of new anthrapyrazole and pyrazoloacridine derivatives.Crit Rev Oncol Hematol. 1996 Mar;22(2):79-87. doi: 10.1016/1040-8428(95)00188-3. Crit Rev Oncol Hematol. 1996. PMID: 8679102 Review. No abstract available.
-
Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors.Invest New Drugs. 2000 Aug;18(3):265-7. doi: 10.1023/a:1006434008357. Invest New Drugs. 2000. PMID: 10958596 Clinical Trial.
-
Pyrazoloacridine is active in multidrug-resistant neuroblastoma cell lines with nonfunctional p53.Clin Cancer Res. 2003 Aug 15;9(9):3492-502. Clin Cancer Res. 2003. PMID: 12960142
-
Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.Gynecol Oncol. 2002 Feb;84(2):241-4. doi: 10.1006/gyno.2001.6491. Gynecol Oncol. 2002. PMID: 11812081 Clinical Trial.
Cited by
-
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.Invest New Drugs. 2002 Aug;20(3):297-304. doi: 10.1023/a:1016237426846. Invest New Drugs. 2002. PMID: 12201492 Clinical Trial.
-
Current status of pyrazoloacridine as an anticancer agent.Invest New Drugs. 1999;17(1):43-8. doi: 10.1023/a:1006242321596. Invest New Drugs. 1999. PMID: 10555121 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical